Abstract
In health care, technologies should be diffused and adapted if their safety and efficacy has been established and determined. The role of making such a decision, that is whether the safety and efficacy of a certain technology is established, is encapsulated within the processes of a “health technology assessment (HTA).” In this way, HTA has had a central role in the development of a transient healthcare, which is constantly adapting to meet ever-evolving demands. HTA is a very useful concept and tool for providing information for evidence-based decision making. And evidence-based decision making is critical when resources should be allocated in health care. Therefore, from all interest parties in society, the consensus on the necessity for conducting HTA should be brought. And governments should incorporate results from HTA into policy making as possible as they can.
Similar content being viewed by others
References
Office of Technology Assessment, Development of medical technology: opportunities for assessment, Washington DC: U.S. Government Printing Office (1976).
International network of agencies for health technology assessment (http://www.inahta.org), Available at website: accessed March 20, 2013.
D Banta, The development of health technology assessment, Health Policy, 63, 121 (2003).
F Sassi, Setting priorities for the evaluation of health interventions: when theory does not meet practice, Health Policy, 63, 141 (2003).
SH Park, SM Lee, Evidence-based decision-making and health technology assessment in South Korea, Value in Health, 11, S163 (2008).
M Perleth, R Busse, Health technology assessment in Germany. Status, challenges, and development, Int J Technol Assess Health Care, 16, 412 (2000).
W Claudia, G Bernhard, Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria, Health Policy, 63, 187 (2003).
O Golan, P Hansen, G Kaplan, et al., Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights, Health Policy, 102, 126 (2011).
I Kamae, Value-based approaches to healthcare systems and pharmacoeconomics requirements in Asia: South Korea, Taiwan, Thailand and Japan, Pharmacoeconomics, 28, 831 (2010).
PJ Feldstein, Health Care Economics, Fifth edition, Delmar Publishers: New York (2002).
JE Stiglitz, CE Walsh, Economics, Third edition, W. W. Norton & Company Ltd: London (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oh, EH. Evidence-based decision making and health technology assessment. Tissue Eng Regen Med 10, 293–295 (2013). https://doi.org/10.1007/s13770-013-1091-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-013-1091-z